David R Carlucci

CIK 1201564 · Chairman, CEO & President · last filed 2020-12-07

David R Carlucci is a Chairman, CEO & President who has filed 38 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $6.7K of MNK on Dec 7, 2020. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $34.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$34.46M

Companies

Total Filings

Lifetime Open-Market Net

-$1.92M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MA price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Keenova Therapeutics plc (MNK) Delisted	Director	0	$0.34	$0	$211.7K	13	2020-12-07
MA	Director	55,266	$623.60	$34.46M	-$2.13M	14	2019-06-27
IMS HEALTH INC (RX) Delisted	Chairman, CEO & President	428,315	—	—	$0	10	2010-02-11

Recent Filings

38 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-12-07	Keenova Therapeutics plc (MNK) Delisted	Sell (S)	−47,107	-$6.7K	EDGAR
2020-05-15	Keenova Therapeutics plc (MNK) Delisted	Tax (F)	−8,729	-$25.8K	EDGAR
2019-06-27	MA	Grant (A)	+828	$0	EDGAR
2019-06-12	MA	Sell (S)	−3,974	-$1.04M	EDGAR
2019-05-17	Keenova Therapeutics plc (MNK) Delisted	Mixed	+10,869	-$129.7K	EDGAR
2018-06-28	MA	Grant (A)	+993	$0	EDGAR
2018-05-18	Keenova Therapeutics plc (MNK) Delisted	Grant (A)	+18,947	$0	EDGAR
2018-03-12	MA	Sell (S)	−5,950	-$1.09M	EDGAR
2017-11-13	Keenova Therapeutics plc (MNK) Delisted	Buy (P)	+10,000	$218.3K	EDGAR
2017-10-03	Keenova Therapeutics plc (MNK) Delisted	Tax (F)	−476	-$17.8K	EDGAR

Showing 1–10 of 38

Page 1 of 4 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.